AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

SIGNED BY GOVERNOR

TRANSMITTED BY SECRETARY OF THE STATE TO GOVERNOR

TRANSMITTED TO SECRETARY OF THE STATE

PUBLIC ACT 25-63

HOUSE PASSED

IN CONCURRENCE

HOUSE CALENDAR NUMBER 526

FAV. RPT., TABLED FOR HOUSE CALENDAR

SENATE PASSED

FAV. RPT., TAB. FOR CAL., SEN.

FILE NO. 384

SENATE CALENDAR NUMBER 235

RPTD. OUT OF LCO

REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 03/31/25

FILED WITH LCO

Joint Favorable

PUBLIC HEARING 0311

REF. TO JOINT COMM. ON Human Services